Current directions for COX-2 inhibition in breast cancer

被引：29

作者：

Chow, LWC ^{[1
]}

Loo, WTY

Toi, M

机构：

[1] Univ Hong Kong, Med Ctr, Dept Hung Chao Hong, Integrated Ctr Breast Dis, Hong Kong, Hong Kong, Peoples R China

[2] Komagome Hosp, Dept Clin Trials & Res, Dept Surg, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan

来源：

BIOMEDICINE & PHARMACOTHERAPY | 2005年 / 59卷

关键词：

current directions; COX-2; inhibition; breast cancer;

D O I：

10.1016/S0753-3322(05)80046-0

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Chemotherapy is effective against breast cancer. COX-2 has been implicated in the progression and angiogenesis of cancers. Celecoxib, a cyclooxygenase type 2 (COX-2) inhibitor, has both apoptotic and antiangiogenic activities, and may be of use in treatment of breast tumors which overexpress the COX-2 enzyme. Preliminary clinical trials have shown that the combination of chemotherapy with celecoxib has minimal additional toxicity and it may enhance the effects of the chemotherapy. Beside chemotherapy, celecoxib may promulgate the effect of aromatase inhibitor in breast cancer cells. Animal studies have shown that there are fewer and smaller tumors treated by combining exemestane and celecoxib. Larger clinical trials should be initiated to study the potential anti-cancer effects of celecoxib in breast cancer. (c) 2005 Elsevier SAS. All rights reserved.

引用

页码：S281 / S284

页数：4

共 76 条

[1]

Abou-Issa HM, 2001, ANTICANCER RES, V21, P3425

[2]

Alshafie GA, 2000, ONCOL REP, V7, P1377

[3] The role of COX-2 inhibition in breast cancer treatment and prevention [J].

Arun, B ;

Goss, P .

SEMINARS IN ONCOLOGY, 2004, 31 (02) :22-29

[4]

Basu GD, 2004, MOL CANCER RES, V2, P632

[5]

Boccardo Francesco, 2004, Clin Breast Cancer, V5 Suppl 1, pS13, DOI 10.3816/CBC.2004.s.009

[6]

Boer Katalin, 2005, Orvosi Hetilap, V146, P15

[7] Aromatase and COX-2 expression in human breast cancers [J].

Brodie, AMH ;

Lu, Q ;

Long, BJ ;

Fulton, A ;

Chen, T ;

Macpherson, N ;

DeJong, PC ;

Blankenstein, MA ;

Nortier, JWR ;

Slee, PHTJ ;

van de Ven, J ;

van Gorp, JMHH ;

Elbers, JRJ ;

Schipper, MEI ;

Blijham, GH ;

Thijssen, JH .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 79 (1-5) :41-47

[8] Aromatase and cyclooxygenases: enzymes in breast cancer [J].

Brueggemeier, RW ;

Richards, JA ;

Petrel, TA .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 86 (3-5) :501-507

[9] A LINK BETWEEN BREAST-CANCER AND LOCAL ESTROGEN BIOSYNTHESIS SUGGESTED BY QUANTIFICATION OF BREAST ADIPOSE-TISSUE AROMATASE CYTOCHROME-P450 TRANSCRIPTS USING COMPETITIVE POLYMERASE CHAIN-REACTION AFTER REVERSE TRANSCRIPTION [J].

BULUN, SE ;

PRICE, TM ;

AITKEN, J ;

MAHENDROO, MS ;

SIMPSON, ER .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06) :1622-1628

[10] Relationship between expression and distribution of cyclooxygenase-2 and bcl-2 in human gastric adenocarcinoma [J].

Chen, Xiao-Li ;

Su, Bao-Shan ;

Sun, Run-Qin ;

Zhang, Jun ;

Wang, Yi-Li .

WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (08) :1228-1231

← 1 2 3 4 5 6 7 8 →